February 20, 2014
1 min read
Save

Low morning, high evening cortisol levels tied to frailty in elderly

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Lower morning cortisol reactivity and higher evening salivary cortisol levels may indicate frailty in older patients, according to data.

“Cortisol typically follows a distinct daily pattern with the highest level in the morning and the lowest basal level at night,” Karl-Heinz Ladwig, PhD, MD, of Helmholtz Zentrum München in Neuherberg, Germany, said in a press release. “Our findings showed dysregulated cortisol secretion, as featured by a smaller morning to evening cortisol level ratio, was significantly associated with frailty status.”

Patients (n=745; mean age, 75.1 years) were previously enrolled in the population-based KORA Age study. In a cross-sectional analysis, the researchers observed lower cortisol levels in the first morning sample (P=.18) and 30 minutes after awakening (P=.14), in addition to increased evening levels (P=.004) among patients categorized as prefrailty (35.17%; n=262) and frail (3.36%; n=25).

Additional data indicate frailty was significantly associated with smaller ratios of morning to evening levels (P=.02) and 30 minutes after awakening-to-evening ratio (P=.003). Moreover, high evening cortisol levels were linked to a 24% increased risk for a prefrailty status (OR=1.22; 95% CI, 1.03-1.44). Similarly, a smaller morning-to-evening ratio was tied to an increased risk for low grip strength (OR=1.42; 95% CI, 1.09-1.86) and gait speed (OR=1.31; 95% CI, 1.02-1.68), researchers wrote.

“Our results suggest a link between disrupted cortisol regulation and loss of muscle mass and strength, as the underlying pathophysiology of frailty,” Hamimatunnisa Johar, a PhD student at Helmholtz Zentrum München, said in a press release. “In a clinical setting assessment of frailty can be time-consuming, and our findings show measurements of cortisol may offer a feasible alternative.”

Disclosure: The researchers report no relevant financial disclosures.